BioVoice News July 2017 Issue 2 Volume 2 | Page 49

T he ‘bioConclave 2017’ which is all set to be held at later this year in London, United Kingdom will provide platform to new exciting projects, case studies, technologies and innovations which are creating impact in the field of Genomics, Big Data, Connected Care and Healthcare Games globally. The event will explore how these ideas are driving research and development and the diagnostics and treatment of diseases today, and in the future. As per the organizers, Economic Policy Group (EPG), the audience will hear views from industry leaders, experience technologies in the exhibition demonstrations, meet and network with leading academics, investors and industry innovators. The conference site allows registered participants to view each other’s profiles and pre-book one on one meetings to take place at the event on 6th September 2017. Participants will have access to the online private community platform with own username and password to connect with attendees. It allows them to create awareness for their product or services and generate leads that they can add to the sales pipeline. It also gives the opportunity for best customer case study to establish awareness and viability to a room full of prospects. The organizers say that participants can sit alongside the leaders in India’s biopharma industry to discuss key challenges of the market. The companies can also showcase their solutions and technology to leading industry leaders by taking a stand on the exhibition floor. They can maximize the brand visibility by taking a stand at a prime location. For a select few companies, customized meetings will be offered based on the needs of the company. The conclave can help them reach out to their prospects and arrange private meetings on-site. Banking on the successful past experiences The past two chapters of bioConclave in 2015 and 2016 have been credited with creating closer collaborations between Indian and European bioscience companies. Lot many prominent personalities from the UK have been associated BIOVOICENEWS.COM 49